Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Return on Equity (2016 - 2021)

GT Biopharma (GTBP) has disclosed Return on Equity for 8 consecutive years, with 0.73% as the latest value for Q3 2021.

  • On a quarterly basis, Return on Equity fell 124.0% to 0.73% in Q3 2021 year-over-year; TTM through Sep 2021 was 0.73%, a 124.0% decrease, with the full-year FY2020 number at 0.27%, changed N/A from a year prior.
  • Return on Equity was 0.73% for Q3 2021 at GT Biopharma, down from 0.72% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 9.65% in Q1 2021 to a low of 22.24% in Q1 2019.
  • A 5-year average of 0.6% and a median of 0.39% in 2018 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -2186bps in 2019, then surged 2403bps in 2020.
  • GT Biopharma's Return on Equity stood at 0.37% in 2017, then plummeted by -438bps to 2.0% in 2018, then surged by 300bps to 4.01% in 2019, then plummeted by -102bps to 0.06% in 2020, then tumbled by -1056bps to 0.73% in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Return on Equity are 0.73% (Q3 2021), 0.72% (Q2 2021), and 9.65% (Q1 2021).